In numbers

Women's health, in numbers

These figures come from public data and published research. Australian and global figures are never mixed in one chart. Methods, sources and caveats for every dataset are in research-data/SOURCES.md.

Chapter 1

Then

Global2001

8 of the 10 prescription drugs recently withdrawn from the US market posed greater health risks for women, a 2001 audit found.

10 withdrawn drugs, 8 riskier for women10 pill shapes, 8 of them highlighted: the drugs that posed greater health risks for women.Riskier for women (8)Not (2)

Four of the eight were prescribed more often to women.

Source: US General Accounting Office, 2001. See: On the timeline: 2001, the entry on GitHub

Chapter 2

Now

Global2010–2025

Women are 35% of heart disease trial participants but carry 39% of the burden.

Half of heart disease trials are less than 28.5% women.

Women's share of trial participants vs women's share of the disease burden, by conditionAlzheimer's and other dementias: 58% of participants, 66% of burden; Low back pain: 57% of participants, 63% of burden; Anxiety disorders: 56% of participants, 61% of burden; Ischaemic heart disease: 35% of participants, 39% of burden; Stroke: 42% of participants, 45% of burden; Osteoarthritis: 62% of participants, 61% of burden; Depressive disorders: 63% of participants, 60% of burden; Rheumatoid arthritis: 79% of participants, 72% of burden; Migraine: 84% of participants, 69% of burden.Women's share of trial participantsWomen's share of the disease burden (DALYs, GBD 2023)Alzheimer's and other dementiasParticipants 58% · Burden 66%Low back painParticipants 57% · Burden 63%Anxiety disordersParticipants 56% · Burden 61%Ischaemic heart diseaseParticipants 35% · Burden 39%StrokeParticipants 42% · Burden 45%OsteoarthritisParticipants 62% · Burden 61%Depressive disordersParticipants 63% · Burden 60%Rheumatoid arthritisParticipants 79% · Burden 72%MigraineParticipants 84% · Burden 69%0%25%50%75%100%
Women's share of trial participants was below their share of the disease burden in 5 of 9 conditions. The biggest shortfall was in Alzheimer's and other dementias (58% of participants, 66% of the burden).
Show the data
Women's share of trial participants and of the disease burden, by condition (sorted by the gap)
ConditionTrialsWomen, all participantsWomen, median trialWomen, share of burden
Alzheimer's and other dementias86258.4%55.6%65.6%
Low back pain23056.5%55.4%62.5%
Anxiety disorders60055.6%63.0%60.9%
Ischaemic heart disease68434.9%28.5%38.8%
Stroke63642.3%40.0%45.2%
Osteoarthritis54961.7%60.1%61.0%
Depressive disorders1,27763.2%65.1%60.4%
Rheumatoid arthritis45079.4%80.1%72.1%
Migraine29083.9%83.9%68.9%

Some trials are counted under more than one condition: 5,578 trial–condition entries, 5,198 distinct trials. Very large trials can skew the "all participants" share; the median trial is shown too.

Our analysis of 5,198 ClinicalTrials.gov trials (2010–2025) that reported participants by sex, compared with GBD 2023 burden (DALYs). Studies that compare with prevalence find similar patterns (Rivera et al., JAMA Netw Open 2025).

Ratio of two sources. Sources: ClinicalTrials.gov, US National Library of Medicine; analysis by Women's Health Gaps; IHME, GBD 2023; Rivera FB et al., JAMA Netw Open 2025. Data: ctgov_vs_gbd_summary.csv, ctgov_trials_sex_by_condition.csv

Global2015–2024

Low back pain gets 18.4 research papers per 100,000 years of healthy life lost. Heart disease gets 61.9.

Conditions people live with, rather than die from, tend to get less research.

Research papers per 100,000 DALYs against the share of burden from living unwell, by conditionMigraine: 100.0% of burden from living unwell, 27.5 papers per 100,000 DALYs; Low back pain: 100.0% of burden from living unwell, 18.4 papers per 100,000 DALYs; Rheumatoid arthritis: 72.6% of burden from living unwell, 1,048.3 papers per 100,000 DALYs; Osteoarthritis: 100.0% of burden from living unwell, 166.8 papers per 100,000 DALYs; Depression: 100.0% of burden from living unwell, 72.7 papers per 100,000 DALYs; Anxiety: 100.0% of burden from living unwell, 50.9 papers per 100,000 DALYs; Dementia: 30.6% of burden from living unwell, 248.5 papers per 100,000 DALYs; Heart disease: 5.2% of burden from living unwell, 61.9 papers per 100,000 DALYs; Stroke: 10.7% of burden from living unwell, 62.3 papers per 100,000 DALYs; Breast cancer: 6.5% of burden from living unwell, 550.0 papers per 100,000 DALYs; Cervical cancer: 2.9% of burden from living unwell, 207.5 papers per 100,000 DALYs; Ovarian cancer: 2.7% of burden from living unwell, 498.5 papers per 100,000 DALYs; Uterine cancer: 9.0% of burden from living unwell, 401.7 papers per 100,000 DALYs.Clearly hits women harder (GBD, uncertainty ranges don't overlap)Other conditions101001,0000%50%100%Share of burden from living unwell →↑ Papers per 100,000 DALYs (log scale)MigraineLow back painRheumatoid arthritisOsteoarthritisDepressionAnxietyDementiaHeart diseaseStrokeBreast cancerCervical cancerOvarian cancerUterine cancer
Across 13 conditions, those whose burden comes mostly from living unwell tend to have fewer research papers per unit of burden (rank correlation -0.53). That is a pattern, not proof.
Show the data
Research papers and type of burden, by condition
ConditionPapers per 100,000 DALYsBurden from living unwellClearly hits women harder
Low back pain18.4100.0%Yes
Migraine27.5100.0%Yes
Anxiety disorders50.9100.0%No
Ischemic heart disease61.95.2%No
Stroke62.310.7%No
Depressive disorders72.7100.0%No
Osteoarthritis166.8100.0%No
Cervical cancer207.52.9%No
Alzheimer's disease and other dementias248.530.6%No
Uterine cancer401.79.0%No
Ovarian cancer498.52.7%No
Breast cancer550.06.5%No
Rheumatoid arthritis1,048.372.6%Yes

PubMed papers 2015–2024 per 100,000 DALYs (GBD 2023). A rough measure of research attention across 13 conditions. Gynaecological conditions are left out because GBD's burden estimates for them are unreliable.

Ratio of two sources. Sources: PubMed, US National Library of Medicine; analysis by Women's Health Gaps; IHME, GBD 2023. Data: research_vs_burden_type.csv, gbd_yld_women_vs_men_2023.csv

GlobalAustralia2023

Australian women live with 2.7× as much ill health from rheumatoid arthritis as men, age for age.

Global2023

Worldwide

How many times higher women's rate of years lived with disability is than men's, Global, 2023Rheumatoid arthritis: 2.4× men's rate; Migraine: 2.2× men's rate.Rheumatoid arthritis2.4× men's rateMigraine2.2× men's rate1× = same as men
Worldwide, women's rate of years lived with disability compared with men's: rheumatoid arthritis 2.4×, migraine 2.2×.
Show the data
Years lived with disability per 100,000, age-standardised, Global, 2023
ConditionWomenMenWomen ÷ men
Rheumatoid arthritis37.915.82.40
Migraine675.2302.12.24

Rows where gap_clear is True only.

Source: Global Burden of Disease Collaborative Network, GBD 2023 Results (IHME, 2024). Data: gbd_yld_women_vs_men_2023.csv

Australia2023

In Australia

How many times higher women's rate of years lived with disability is than men's, Australia, 2023Rheumatoid arthritis: 2.7× men's rate; Migraine: 2.2× men's rate; Low back pain: 2.0× men's rate.Rheumatoid arthritis2.7× men's rateMigraine2.2× men's rateLow back pain2.0× men's rate1× = same as men
In Australia, women's rate of years lived with disability compared with men's: rheumatoid arthritis 2.7×, migraine 2.2×, low back pain 2.0×.
Show the data
Years lived with disability per 100,000, age-standardised, Australia, 2023
ConditionWomenMenWomen ÷ men
Rheumatoid arthritis62.923.12.72
Migraine611.1282.32.16
Low back pain1,631.2831.81.96

Rows where gap_clear is True only.

Source: Global Burden of Disease Collaborative Network, GBD 2023 Results (IHME, 2024). Data: gbd_yld_women_vs_men_2023.csv

Years lived with disability (YLDs) per 100,000, age-standardised. Rows shown only where the uncertainty ranges for women and men don't overlap.

Global2021

In all 183 countries with WHO estimates, women spend more years in ill health than men.

Years lived in ill health, women and men, by WHO region, 2021Americas: women 12.5, men 9.3 years; Europe: women 12.0, men 8.7 years; Eastern Mediterranean: women 10.9, men 8.1 years; Western Pacific: women 10.7, men 7.9 years; South-East Asia: women 10.4, men 7.7 years; Africa: women 9.7, men 7.1 years.WomenMenAmericas9.312.5Europe8.712.0Eastern Mediterranean8.110.9Western Pacific7.910.7South-East Asia7.710.4Africa7.19.746810121416Years in ill health (years)
In every WHO region, women spend more years in ill health than men. The gap ranges from 2.6 years (Africa) to 3.3 years (Europe).
Show the data
Years lived in ill health by WHO region, 2021
WHO regionWomenMenDifference
Americas12.519.283.23
Europe11.988.693.29
Eastern Mediterranean10.938.072.86
Western Pacific10.687.912.77
South-East Asia10.447.662.78
Africa9.677.122.55

Countries where women's figure is higher than men's: 183 of 183 (geo_type COUNTRY, 2021).

Years in ill health is life expectancy minus healthy life expectancy. 2021 estimates, which include the effects of COVID-19.

Source: WHO Global Health Estimates 2021. Data: who_le_hale_by_sex.csv

AustraliaAIHW 2025

60% of Australian women's burden of disease comes from living with illness, not from dying early.

Burden of disease: living with illness vs dying early, AustraliaWomen: 60% living with illness, 40% dying early.WomenLiving with illness 60%Dying early 40%
Of all the healthy life Australian women lose to disease, 60% is lost to living with illness and 40% to dying early.
Show the data
Share of the burden of disease, Australia (%)
Living with illnessDying early
Women60%40%

Transcribed from AIHW, The health of women in Australia (2025), as cited on the home page. The source as cited gives women's figure only, so men aren't shown.

Burden of disease counts the years of healthy life lost, both to living with illness and to dying early.

Source: AIHW, The health of women in Australia (2025). Data: aihw_burden_fatal_nonfatal.csv

Australia2025

Coronary heart disease killed 5,965 Australian women in 2025. Breast cancer killed 3,244.

Deaths of Australian women from coronary heart disease and breast cancer, 2025Coronary heart disease: 5,965 deaths, shown as 60 figures. Breast cancer: 3,244 deaths, shown as 32 figures. One figure = 100 deaths.Coronary heart disease5,965 deaths · about 16 a dayBreast cancer3,244 deaths · about 9 a day
About 16 women a day died from coronary heart disease, and about 9 a day from breast cancer. Each figure stands for 100 deaths, rounded to the nearest 100.
Show the data
Australian women, deaths registered in 2025
Cause (ABS name)DeathsDeaths a dayYears of potential life lost
Ischaemic heart diseases (I20-I25)5,96516.313,959
Malignant neoplasm of breast (C50)3,2448.925,503

Deaths a day = deaths ÷ 365.

Breast cancer kills women younger, so it costs more years of life: 25,503 years of potential life lost, compared with 13,959 for coronary heart disease.

Source: ABS, Causes of Death, Australia, 2025. Data: abs_cod_2025_by_cause_sex.csv

Chapter 3

Still to go

Australia1990–2023

Heart disease death rates for Australian women fell by 80% between 1990 and 2023.

Age-standardised death rates per 100,000, Australian women, 1990, 2010, 2023Heart disease: 132.2 → 47.9 → 26.1 (down 80%); Stroke: 61.3 → 29.4 → 17.8 (down 71%); Breast cancer: 26.5 → 18.4 → 14.4 (down 46%); Ovarian cancer: 7.3 → 5.8 → 4.6 (down 36%); Cervical cancer: 3.8 → 2.3 → 2.0 (down 47%).Deaths per 100,000 women (age-standardised)070140199020102023Heart disease −80%Stroke −71%Breast cancer −46%Ovarian cancer −36%Cervical cancer −47%
Fall in age-standardised death rates for Australian women, 1990 to 2023: heart disease 80%, stroke 71%, breast cancer 46%, ovarian cancer 36%, cervical cancer 47%.
Show the data
Age-standardised death rates per 100,000, Australian women (GBD 2023)
Cause199020102023Fall, 1990–2023
Heart disease132.247.926.180.3%
Stroke61.329.417.870.9%
Breast cancer26.518.414.445.8%
Ovarian cancer7.35.84.636.4%
Cervical cancer3.82.32.046.7%

Age-standardised rates; falls are similar for men. Investment in research, prevention and treatment works.

Source: Global Burden of Disease Collaborative Network, GBD 2023 Results (IHME, 2024). Data: gbd_au_women_death_rates_1990_2023.csv

Australia2025

Ovarian cancer killed 1,043 Australian women in 2025. Cervical cancer killed 250.

Australia2025

Deaths: ovarian and cervical cancer

Cervical cancer has a national screening program. Ovarian cancer has no screening test.

Deaths of Australian women from ovarian and cervical cancer, 2025Ovarian cancer: 1,043 deaths. Cervical cancer: 250 deaths.Ovarian cancerDeaths 1,043Cervical cancerDeaths 250
Deaths of Australian women registered in 2025: ovarian cancer 1,043, cervical cancer 250.
Show the data
Australian women, deaths registered in 2025
Cause (ABS name)Deaths
Malignant neoplasm of ovary (C56)1,043
Malignant neoplasm of cervix uteri (C53)250

Source: ABS, Causes of Death, Australia, 2025. Data: abs_cod_2025_by_cause_sex.csv

Australia2024

Screening: Australia and other countries

Share of women screened, Australia vs the median of other countries reporting (OECD programme data)Cervical screening: Australia 77.9%, other countries' median 60.6%; Breast screening: Australia 52.0%, other countries' median 53.8%.Cervical screening (ages 20–69)Australia 77.9%Other countries, median 60.6%Breast screening (ages 50–69)Australia 52.0%Other countries, median 53.8%
Cervical screening (ages 20–69), 2024: Australia 77.9%, median of 36 other countries 60.6%. Breast screening (ages 50–69), 2024: Australia 52.0%, median of 38 other countries 53.8%.
Show the data
Women screened, programme data (%)
ScreeningYearAustraliaMedian, other countriesCountries reporting
Cervical screening (ages 20–69)202477.9%60.6%36
Breast screening (ages 50–69)202452.0%53.8%38

OECD status for Australia: cervical screening "Definition differs".

OECD measures breast screening at ages 50–69; BreastScreen Australia invites women aged 50–74. OECD flags Australia's cervical screening figure: "Definition differs".

Source: OECD Health Statistics, cancer screening. Data: oecd_cancer_screening.csv

AustraliaSurvey 2017

People with endometriosis in Australia waited an average of eight years from their first symptoms to a diagnosis.

Average years from first seeing a doctor to an endometriosis diagnosis, Australia, by when people first saw a doctorbefore 2005, 9.9 years; 2005–2012, 4.8 years; 2013 onwards, 1.5 years. Survey of 340 people, 2017.First saw a doctor before 2005 9.9 yearsFirst saw a doctor 2005–2012 4.8 yearsFirst saw a doctor 2013 onwards 1.5 years
Average years from first seeing a doctor to an endometriosis diagnosis, by when people first saw a doctor: before 2005, 9.9 years; 2005–2012, 4.8 years; 2013 onwards, 1.5 years. Waits have got shorter, but the most recent group is cut short (see below).
Show the data
Average years from first seeing a doctor to an endometriosis diagnosis (survey of 340 people, 2017)
First saw a doctorAverage years to diagnosis
before 20059.9
2005–20124.8
2013 onwards1.5

The survey ran in 2017, so people first seen from 2013 who were still waiting weren't counted. A 2025 survey of 506 Australians found an average of 12.3 years from symptoms to diagnosis, and 4.7 years for people who first saw a GP from 2018. Both surveys recruited through endometriosis groups, so they aren't representative.

Sources: Armour et al., Scientific Reports (2020); Mosterd et al., Journal of Psychosomatic Research (2025). Data: time_to_diagnosis.csv

What needs to change, and who can change it